Can Gilead Dominate The HIV Drug Market Again in 2014?

In the fourth quarter, Gilead sold $204 million worth of the drug, suggesting Stribild --- approved by the FDA in late 2012 -- could become a blockbuster this year.

http://ift.tt/1nOMjyO